部分精神分裂症患者脑内蛋白质不溶性增加
该研究对精神分裂症患者及对照者死后脑组织的前额叶皮层和颞上回进行冷sarkosyl分级分离,分离可溶与不可溶蛋白,量化不溶部分的蛋白质不溶性和泛素水平,并行质谱分析。结果显示一部分精神分裂症脑组织不溶部分蛋白质不溶性和泛素化增加,不溶部分显著改变的蛋白质富集于轴突靶向识别及神经系统发育与功能通路。结论提示部分精神分裂症患者存在与蛋白质不溶性相关的病理过程。
要点
- 部分精神分裂症患者脑不溶部分蛋白质不溶性和泛素化增加。
- 不溶部分改变的蛋白质富集于轴突靶向识别和神经系统发育通路。
- 该亚型分子机制或有助于理解临床表型及发现新治疗靶点。
核心结论
- 研究提示一部分精神分裂症患者存在与蛋白质不溶性相关的病理过程。
- 确定该亚型的分子机制可能有助于理解某些重性精神疾病患者的临床表型、改进疾病分类和识别新治疗靶点。
研究设计与样本
- 研究对精神分裂症患者及无精神分裂症个体的死后脑组织前额叶皮层和颞上回进行冷sarkosyl分级分离,分离可溶与不可溶蛋白。
- 对每个不溶部分量化蛋白质不溶性和泛素水平,并以总匀浆蛋白归一化。
- 对不溶部分行质谱分析鉴定蛋白质内容,并用Gene Ontology富集分析和Ingenuity Pathway Analysis评估生物学相关性。
主要发现
- 一部分精神分裂症脑组织在不溶部分显示蛋白质不溶性和泛素化增加。
- 对不溶部分行质谱分析,主成分分析显示不溶性和泛素化增加的脑组织具有相似的肽表达。
- 不溶部分显著改变的蛋白质富集于轴突靶向识别以及神经系统发育与功能相关通路。
临床怎么用
- 该发现提示对精神分裂症患者可依据蛋白质不溶性病理进行亚型划分的潜在方向。
- 明确该亚型分子机制可能为改进疾病分类和识别新治疗靶点提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The mechanisms leading to schizophrenia are likely to be diverse. However, there may be common pathophysiological pathways for subtypes of the disease. The authors tested the hypothesis that increased protein insolubility and ubiquitination underlie the pathophysiology for a subtype of schizophrenia. METHODS: Prefrontal cortex and superior temporal gyrus from postmortem brains of individuals with and without schizophrenia were subjected to cold sarkosyl fractionation, separating proteins into soluble and insoluble fractions. Protein insolubility and ubiquitin levels were quantified for each insoluble fraction, with normalization to total homogenate protein. Mass spectrometry analysis was then performed to identify the protein contents of the insoluble fractions. The potential biological relevance of the detected proteins was assessed using Gene Ontology enrichment analysis and Ingenuity Pathway Analysis. RESULTS: A subset of the schizophrenia brains showed an increase in protein insolubility and ubiquitination in the insoluble fraction. Mass spectrometry of the insoluble fraction revealed that brains with increased insolubility and ubiquitination exhibited a similar peptide expression by principal component analysis. The proteins that were significantly altered in the insoluble fraction were enriched for pathways relating to axon target recognition as well as nervous system development and function. CONCLUSIONS: This study suggests a pathological process related to protein insolubility for a subset of patients with schizophrenia. Determining the molecular mechanism of this subtype of schizophrenia could lead to a better understanding of the pathways underlying the clinical phenotype in some patients with major mental illness as well as to improved nosology and identification of novel therapeutic targets.
引用
- Nucifora LG, MacDonald ML, Lee BJ, et al. Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia. Am J Psychiatry. 2019. PMID: 31055969. doi:10.1176/appi.ajp.2019.18070864
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。